Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
0(0%)
Results Posted
38%(6 trials)

Phase Distribution

Ph phase_3
8
50%
Ph phase_1
4
25%
Ph phase_2
4
25%

Phase Distribution

4

Early Stage

4

Mid Stage

8

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
4(25.0%)
Phase 2Efficacy & side effects
4(25.0%)
Phase 3Large-scale testing
8(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

16 of 16 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Completed(16)

Detailed Status

Completed16

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (25.0%)
Phase 24 (25.0%)
Phase 38 (50.0%)

Trials by Status

completed16100%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT00603382Phase 2

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.

Completed
NCT00117325Phase 3

Study Of Adults And Adolescents With Vasomotor Rhinitis

Completed
NCT00419237Phase 1

Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function

Completed
NCT00603746Phase 2

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

Completed
NCT00118703Phase 3

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis

Completed
NCT00444509Phase 1

Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.

Completed
NCT00522678Phase 1

Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers

Completed
NCT00972673Phase 1

A Study of GW685698X in Healthy Japanese Male Subjects

Completed
NCT00108914Phase 3

Perennial Allergic Rhinitis Study In Pediatric Subjects

Completed
NCT00603278Phase 2

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.

Completed
NCT00766090Phase 2

Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma

Completed
NCT00224523Phase 3

Long Term Safety Of GW685698X Via Nasal Biopsy

Completed
NCT00103454Phase 3

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

Completed
NCT00107757Phase 3

Seasonal Allergic Rhinitis In Pediatric Subjects

Completed
NCT00109486Phase 3

Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

Completed
NCT00225823Phase 3

Study In Adults And Adolescents With Seasonal Allergic Rhinitis.

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16